Interesting article in the Guardian recently for anyone who has been impacted by the effects of Alzheimer's disease. Researchers in Toronto have discovered a new drug with the potential to not only stop, but actually improve, memory loss. Clinical trials could start in the next two years on the drug which is derived from benzodiazepine. This is already being considered for application in relation to a number of conditions including Alzheimer's disease and depression. Research and development into drugs like these can give hope to those suffering from these conditions and their families.
| less than a minute read
New drug with potential to reverse memory loss
“Our findings have direct implications for poor cognition in normal ageing,” he said, with the drug potentially improving learning, memory, decision making and essential life planning. “But we see this deficiency across disorders from depression to schizophrenia and Alzheimer’s.”
This week our Life Sciences team published the first edition of its Cross-border Guide to Clinical Trials and Privacy. The Guide will...